RNAi Technology Market Size, Growth, Outlook, Trends, and Forecast Report 2023-2030

RNAi Technology Market Overview
RNA interference (RNAi) is a technique that uses small nucleic acid fragments to post-transcriptionally silence genes in order to cure cancer and other diseases. This method allows for the modification of proteins to make them more target-specific even in the absence of the enzyme pocket necessary for binding.

This approach could lead to the identification of the target genes and the functional assessment of significant disease genes, ultimately leading to the development of effective medications. RNA interference (RNAi)-based therapeutics provide a strong way to quickly find precise and effective inhibitors of disease targets across all molecular classes.

In addition, the market for RNAi technology is growing due to the growing demand for precise gene silencing in a variety of applications, such as medicine development and agricultural biotechnology, and the expansion of research in these areas.

RNAi Technology Market Size and Growth Analysis
The global RNAi Technology Market reached US$ 1.6 billion in 2022 and is expected to reach US$ 3.6 billion by 2030 growing with a CAGR of 10.3% during the forecast period 2023-2030.

Download a Free PDF Sample - https://www.datamintelligence.com/download-sample/rnai-technology-market

RNAi Technology Market Dynamics
Some of the factors propelling the growth of the global RNAi technology market include the rise in genetic and metabolic disorders, the growth of molecular diagnostics applications, the prevalence of cancer, and the expansion of research and development for drug discovery. RNA interference (RNAi) has several advantages in cancer therapy, such as low cost, high specificity, and effective growth control of tumors in advanced stages.

By employing RNA interference (RNAi) to simultaneously disrupt many genes in distinct pathways, drug resistance may be reduced. For example, researchers found that the EGFR/ERK/AP-1 pathway may decrease P-glycoprotein expression and reverse MDR when SH3GL1 is inhibited using siRNA. As more effective delivery methods are developed, RNAi may also be used to give specific patients customized drugs as adjuvants to chemotherapy.

For more detailed information - https://www.datamintelligence.com/research-report/rnai-technology-market

RNAi Technology Segment Analysis

By Type
By Application
By End User
By Region

Major Companies Covered
Alnylam Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc., Atalanta Therapeutics, Phio Pharmaceuticals, Benitec Biopharma, Novartis AG, AstraZeneca, Silence Therapeutics, Arbutus Biopharma and Sylentis S.A. among others.

Trending Report
Liquid Handling System Market: https://www.datamintelligence.com/research-report/liquid-handling-system-market

Clinical Chemistry Analyzers Market: https://www.datamintelligence.com/research-report/clinical-chemistry-analyzers-market

Chromatography Systems Market: https://www.datamintelligence.com/research-report/chromatography-systems-market

Gene Prediction Tool Market: https://www.datamintelligence.com/research-report/gene-prediction-tool-market

Gene Editing Tools Market: https://www.datamintelligence.com/research-report/gene-editing-tools-market

3D Bioprinting Market: https://www.datamintelligence.com/research-report/3d-bioprinting-market

Tissue Engineering Market: https://www.datamintelligence.com/research-report/tissue-engineering-market

Cell Therapy Market: https://www.datamintelligence.com/research-report/cell-therapy-market

Contact Us:
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

DataM Intelligence 4market Research LLP Ground floor, DSL Abacus IT Park, Industrial Development Area, Uppal, Hyderabad, Telangana 500039

About DataM Intelligence:
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.